|
Volumn 63, Issue 2, 2001, Pages 92-101
|
Prostaglandin E inhibits indomethacin-induced gastric lesions through EP-1 receptors
|
Author keywords
EP receptor knockout mouse; EP1 receptor; Gastric lesion; Gastric motility; Indomethacin; Neutrophil chemotaxis; Prostaglandin E
|
Indexed keywords
11 DEOXYPROSTAGLANDIN E1;
17 PHENYLPROSTAGALNDIN E2;
ATROPINE;
BUTAPROST;
INDOMETACIN;
ONO AE 829;
ONO NT 012;
PROSTAGLANDIN E RECEPTOR;
PROSTAGLANDIN E2;
RECEPTOR BLOCKING AGENT;
RECEPTOR SUBTYPE;
SULPROSTONE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
DRUG INHIBITION;
DRUG RECEPTOR BINDING;
KNOCKOUT MOUSE;
LEUKOCYTE ACTIVATION;
MALE;
MOUSE;
NEUTROPHIL CHEMOTAXIS;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
STOMACH LESION;
STOMACH MOTILITY;
STOMACH PROTECTION;
TREATMENT OUTCOME;
ANIMALS;
DINOPROSTONE;
GASTRIC MUCOSA;
GASTROINTESTINAL MOTILITY;
INDOMETHACIN;
MALE;
MICE;
MICE, KNOCKOUT;
NEUTROPHIL ACTIVATION;
NEUTROPHIL INFILTRATION;
PROSTAGLANDINS E;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, PROSTAGLANDIN E;
STOMACH DISEASES;
|
EID: 0035107738
PISSN: 00122823
EISSN: None
Source Type: Journal
DOI: 10.1159/000051876 Document Type: Article |
Times cited : (51)
|
References (45)
|